Bayer is signaling it has had enough of litigation, leaving the future of a crop protection tool in limbo.
Executives tell the Wall Street Journal they are nearing the end of the road for glyphosate, the main ingredient in RoundUp. CEO Bill Anderson says they are barely breaking even, and litigation costs often put them in the red.
More than 65,000 cases are pending against Bayer right now, and the company has around $16 billion set aside for settlements.
Anderson stands by glyphosate, saying it has been proven safe to use, even by the FDA. Bayer produces roughly 40 percent of the supply used by U.S. farmers.
Related Stories
Bipartisan momentum builds, but final farm policy remains unsettled.
Valley Irrigation’s Darren Siekman explains the advantages of their new pivots for growers managing acreages of up to 60 acres.
Jeramy Stephens with National Land Realty explains how the Supreme Court’s tariff ruling and ongoing ‘America First’ trade policy raise new questions about U.S. farmland values and agricultural market stability.
Farm bill negotiations remain unsettled, leaving producers waiting for updated federal support programs.
Roger McEowen of Washburn University School of Law joined us to discuss key legal and tax issues ranchers should consider as they recover from recent prairie fires across the Southern Plains.
Texas lawmakers secure funding for sterile fly production as officials work to stop the New World screwworm from spreading into the U.S. cattle herd.
